| Drug Name | Roaccutane(Isotretinoin) |
|---|---|
| Drug Class | |
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Dermatology
|
| Risk |
Risk of teratogenicity . |
| patient guide |
|
| patient consent form |
|
| Dear Healthcare provider letter DHPC |
|
| other |
Contraception information brochure for ISOTRETINOIN PATIENTS
DHPC 11/09/2019 |